共 32 条
[1]
Cerchione C(2017)Pegfilgrastim in primary prophylaxis of febrile neutropenia following frontline bendamustine plus rituximab treatment in patients with indolent non-Hodgkin lymphoma: a single center, real-life experience Support Care Cancer 25 839-845
[2]
De Renzo A(2008)Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP Ann Hematol 87 277-283
[3]
Di Perna M(2015)Phase II study of bendamustine combined with rituximab in relapsed/refractory mantle cell lymphoma: efficacy, tolerability, and safety findings Ann Hematol 94 2025-2032
[4]
Della Pepa R(2008)Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin’s lymphoma J Clin Oncol 26 4473-4479
[5]
Pugliese N(undefined)undefined undefined undefined undefined-undefined
[6]
Catalano L(undefined)undefined undefined undefined undefined-undefined
[7]
Pane F(undefined)undefined undefined undefined undefined-undefined
[8]
Picardi M(undefined)undefined undefined undefined undefined-undefined
[9]
Bosly A(undefined)undefined undefined undefined undefined-undefined
[10]
Bron D(undefined)undefined undefined undefined undefined-undefined